Research and Markets: Fibrosarcoma Pipeline Review, H2 2015 - 6 Companies 9 Drug Profiles

Business News
Print
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9gplbz/fibrosarcoma) has announced the addition of the "Fibrosarcoma - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Fibrosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest up

imageimage
image